Trial intelligence / Profile preview

Hyperthermic vs Normothermic IP Paclitaxel in Ovarian Cancer

NCT02739698Phase 2Completed

Sponsor
Maimónides Institute of Biomedical Research of Córdoba
Start
Jul 2012
Primary completion
Nov 2014
Modality
Small Molecules
01

Overview

A Phase 2 trial of paclitaxel in peritoneal carcinomatosis (PC), ovarian cancer, sponsored by Maimónides Institute of Biomedical Research of Córdoba. Started Jul 2012; status: completed.

02

Drugs

paclitaxel
03

Conditions

peritoneal carcinomatosis (PC)ovarian cancer

Beyond the preview

Go deeper on NCT02739698.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02739698.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call